Skip to main navigation Skip to search Skip to main content

Mycobacterium abscessus genomic epidemiology in Northern Ireland, UK

  • Zoe Johnston
  • , Mark Smyth
  • , Michaela McClean
  • , James McKenna
  • , Marc Niebel
  • , Timothy Shaw
  • , Derek Fairley

Research output: Contribution to conferencePoster

1 Downloads (Pure)

Abstract

Background:
Mycobacterium abscessus complex are non-tuberculous environmental mycobacteria that
cause a spectrum of opportunistic human disease, especially in patients with underlying
respiratory conditions and the immunosuppressed. Intrinsic resistance to many antibiotics
makes treatment of M. abscessus infections very challenging and transmission within
vulnerable groups, especially cystic fibrosis patients, is possible. Recent whole genome
sequencing studies (Bronson et al, 2021; Diricks et al, 2022) have found M. abscessus is
genomically diverse, although almost indistinguishable clonal strains have also been isolated
from patients in different countries, suggesting international spread via as-yet unrecognised
routes. No studies have been done to date in Northern Ireland to investigate genomic
diversity of this pathogen, or possible transmission between patients.

Methods:
We performed whole genome sequencing on a collection of 48 M. abscessus strains isolated
between 2021 and 2023 from 22 different patients in Northern Ireland. Speciation used a
commercial (HAIN GenoType Mycobacterium CM v2.0) assay, compared to whole genome
data. Conventional 7-locus multi-locus sequence typing (MLST), core genome multi-locus
sequence typing (cgMLST) and core genome single nucleotide polymorphism (cgSNP)
analyses were then used to compare isolates within and between patients.

Results:
44/48 of isolates were identified as M. abscessus ssp. abscessus and 4/48 isolates (all from
the same patient) were M. abscessus ssp. Massiliense, with 100% concordance between
methods. 10 different MLST sequence types (ST5, ST9, ST23, ST24, ST34, ST39, ST40,
ST97, ST101, ST108, and one new profile) and 14 different cgMLST sequence types were
identified. There were three multi-patient clusters: ST5, ST9 and ST34. The ST5 (clonal
complex 1) cluster was further resolved by cgMLST into 4 different sequence types,
corresponding to 4 different patients within the cluster. However cgSNP analysis was
required to resolve strains within both the ST9 (clonal complex 2) and ST34 clusters.

Conclusions:
This study confirms the usefulness of both conventional MLST and cgMLST to rule-out
transmission between individual M. abscessus cases, but further cgSNP analysis was
necessary to resolve strains within some sequence types.
Original languageEnglish
Publication statusPublished - 28 Apr 2024
Event34th European Congress of Clinical Microbiology & Infectious Diseases, Barcelona, Spain - Barcelona, Spain
Duration: 27 Apr 202430 Apr 2024

Conference

Conference34th European Congress of Clinical Microbiology & Infectious Diseases, Barcelona, Spain
Period27/04/202430/04/2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Mycobacterium abscessus genomic epidemiology in Northern Ireland, UK'. Together they form a unique fingerprint.

Cite this